Literature DB >> 11830479

Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

Patricia Algara1, Marisol S Mateo, Margarita Sanchez-Beato, Manuela Mollejo, Immaculada C Navas, Lourdes Romero, Francesc Solé, Marta Salido, Lourdes Florensa, Pedro Martínez, Elias Campo, Miguel A Piris.   

Abstract

This study aimed to correlate the frequency of somatic mutations in the IgV(H) gene and the use of specific segments in the V(H) repertoire with the clinical and characteristic features of a series of 35 cases of splenic marginal zone lymphoma (SMZL). The cases were studied by seminested polymerase chain reaction by using primers from the FR1 and J(H) region. The results showed unexpected molecular heterogeneity in this entity, with 49% unmutated cases (less than 2% somatic mutations). The 7q31 deletions and a shorter overall survival were more frequent in this group. Additionally a high percentage (18 of 40 sequences) of SMZL cases showed usage of the V(H)1-2 segment, thereby emphasizing the singularity of this neoplasia, suggesting that this tumor derives from a highly selected B-cell population and encouraging the search for specific antigens that are pathogenically relevant in the genesis or progression of this tumor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830479     DOI: 10.1182/blood.v99.4.1299

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.

Authors:  Silvia Zibellini; Daniela Capello; Francesco Forconi; Paolo Marcatili; Davide Rossi; Sara Rattotti; Silvia Franceschetti; Elisa Sozzi; Emanuele Cencini; Roberto Marasca; Luca Baldini; Alessandra Tucci; Francesco Bertoni; Francesco Passamonti; Ester Orlandi; Marzia Varettoni; Michele Merli; Silvia Rizzi; Valter Gattei; Anna Tramontano; Marco Paulli; Gianluca Gaidano; Luca Arcaini
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

3.  Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.

Authors:  George Kanellis; Manuela Mollejo; Santiago Montes-Moreno; Socorro-María Rodriguez-Pinilla; Juan C Cigudosa; Patricia Algara; Carlos Montalban; Estella Matutes; Andrew Wotherspoon; Miguel A Piris
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

4.  T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.

Authors:  Xavier Sagaert; Brigitte Maes; Vera Vanhentenrijk; Mathijs Baens; Eric Van Cutsem; Gert De Hertogh; Karel Geboes; Thomas Tousseyn
Journal:  World J Gastrointest Oncol       Date:  2011-02-15

Review 5.  Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.

Authors:  Sabarish Ayyappan; Basem M William
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

6.  Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.

Authors:  Shuhua Yi; Yuting Yan; Wenjie Xiong; Rui Lv; Zhen Yu; Wei Liu; Enbin Liu; Heng Li; Huimin Liu; Zengjun Li; Gang An; Yan Xu; Kun Ru; Dehui Zou; Lugui Qiu
Journal:  Oncotarget       Date:  2017-10-19

7.  Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Maria K Angelopoulou; Sotirios Sachanas; Flora N Kontopidou; Xanthi Yiakoumis; Stella I Kokoris; Evagelia M Dimitriadou; Maria N Dimopoulou; Maria Moschogiannis; Penelope Korkolopoulou; Marie-Christine Kyrtsonis; Marina P Siakantaris; Theodora Papadaki; Panayiotis Tsaftaridis; Eleni Plata; Helen E Papadaki; Theodoros P Vassilakopoulos
Journal:  Oncologist       Date:  2013-01-23

8.  [Splenic marginal zone B cell lymphomas].

Authors:  M M Ott; H K Müller-Hermelink
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

9.  Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.

Authors:  Anne Tierens; Jan Delabie; Agnieszka Malecka; Junbai Wang; Alicja Gruszka-Westwood; Daniel Catovsky; Estella Matutes
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

10.  No V(H) somatic hypermutation was detected in B-cells of a patient with macroglobulinemia due to splenic marginal zone lymphoma.

Authors:  Tetsuaki Sekikawa; Shinobu Takahara; Takeshi Kawano; Shuji Nakada; Kiyoshi Ito; Satsuki Iwase; Hisashi Yamada; Masayuki Kobayashi; Junko Horiguchi-Yamada
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.